25 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... for Preventing ... Women with in HIV-AIDS ... Preventing First ... HumanPapillomavirus #IDSA
Breast Cancer Mammography Screening Decision Aid - Age 50–69

Canadian Task Force on Preventive Health Care

#Diagnosis #PrimaryCare
Screening Decision Aid ... - Age 50–69 Canadian ... Task Force on Preventive ... #Diagnosis #PrimaryCare ... #Mammography #DecisionAid
Breast Cancer Mammography Screening Decision Aid - Age 40–49

Canadian Task Force on Preventive Health Care

#Diagnosis #PrimaryCare
Screening Decision Aid ... - Age 40–49 Canadian ... Task Force on Preventive ... #Diagnosis #PrimaryCare ... #Mammography #DecisionAid
Breast Cancer Mammography Screening Decision Aid - Age 70–74

Canadian Task Force on Preventive Health Care

#Diagnosis #PrimaryCare
Screening Decision Aid ... - Age 70–74 Canadian ... Task Force on Preventive ... #Diagnosis #PrimaryCare ... #Mammography #DecisionAid
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... for Preventing ... Infections in HIV-AIDS ... Preventing 1st ... Penicilliosis #IDSA
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... for Preventing ... Infections in HIV-AIDS ... Preventing Bacterial ... Enteric #Bacterial #IDSA
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... for Preventing ... Trypanosomiasis) in HIV-AIDS ... Preventing Clinical ... Trypanosomiasis #IDSA
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... for Preventing ... Encephalitis in HIV-AIDS ... #Encephalitis #IDSA ... #Prevention #Treatment
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
IDSA Recommendations ... for Preventing ... Disease (MCD) in HIV-AIDS ... Preventing Development ... KaposiSarcoma #Castlemans #IDSA
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... Candidiasis in HIV-AIDS ... 400 mg) PO or IV ... candida #mucosal #IDSA ... #Prevention #Treatment